Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® in Healthy Subjects Aged 9 to 13 Years in Malaysia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02993757
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:44.676289+00:00
Published At
2020-06-11T00:00:00+00:00
Record Updated At
2022-03-25
Results Posted At
2020-06-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Dengue Fever", "Dengue Hemorrhagic Fever", "Human Papillomavirus Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-25"
protocolSection.identificationModule.nctId
"NCT02993757"
protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil\u00ae in Healthy Subjects Aged 9 to 13 Years in Malaysia"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-06-11"

Study condition terms

  • Dengue Fever (protocolSection.conditionsModule.conditions)
  • Dengue Hemorrhagic Fever (protocolSection.conditionsModule.conditions)
  • Human Papillomavirus Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.